IRIS
STAROPOLI, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 834
AS - Asia 657
EU - Europa 483
SA - Sud America 203
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 22
OC - Oceania 2
Totale 2.256
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 796
IT - Italia 278
SG - Singapore 258
BR - Brasile 155
CN - Cina 129
VN - Vietnam 93
DE - Germania 73
IN - India 52
BD - Bangladesh 40
HK - Hong Kong 37
GB - Regno Unito 31
CA - Canada 22
FI - Finlandia 20
AR - Argentina 17
NL - Olanda 16
SE - Svezia 14
RU - Federazione Russa 13
ID - Indonesia 10
MX - Messico 10
TR - Turchia 9
EC - Ecuador 8
CL - Cile 7
ES - Italia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
FR - Francia 6
ZA - Sudafrica 6
CO - Colombia 5
IQ - Iraq 4
JP - Giappone 4
PK - Pakistan 4
AT - Austria 3
CR - Costa Rica 3
KE - Kenya 3
MA - Marocco 3
PL - Polonia 3
PY - Paraguay 3
SC - Seychelles 3
EG - Egitto 2
JO - Giordania 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
KG - Kirghizistan 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 2.202
Salva come PNG Salva come JPEG
Città #
San Jose 153
Singapore 102
Ashburn 94
Dallas 73
Munich 59
Chandler 46
Ho Chi Minh City 41
Santa Clara 40
Bengaluru 36
Hefei 36
Hong Kong 35
Milan 32
Council Bluffs 30
Chicago 25
Beijing 24
London 21
New York 21
Turku 19
Hanoi 18
Catanzaro 17
Los Angeles 16
Rome 15
São Paulo 15
Naples 13
Carbonia 12
Lawrence 11
Princeton 11
The Dalles 11
Wilmington 9
Boardman 7
Ottawa 7
Parma 7
Amsterdam 6
Guangzhou 6
Haiphong 6
Montreal 6
Bologna 5
Buffalo 5
Charlotte 5
Orem 5
Boston 4
Brasília 4
Chennai 4
Da Nang 4
Ercolano 4
Melito di Porto Salvo 4
Messina 4
Olomouc 4
Porto Alegre 4
Reggio Calabria 4
Santiago 4
Shanghai 4
Tokyo 4
Afragola 3
Ankara 3
Atlanta 3
Belo Horizonte 3
Biên Hòa 3
Campina Grande 3
Carapicuíba 3
Catania 3
Curitiba 3
Guayaquil 3
Houston 3
Manaus 3
Moscow 3
Nairobi 3
Nuremberg 3
Redmond 3
Rio de Janeiro 3
Santo Stefano di Rogliano 3
Warsaw 3
Albignasego 2
Amman 2
Augusta 2
Barquisimeto 2
Benevento 2
Bisignano 2
Bismarck 2
Brooklyn 2
Campinas 2
Canoas 2
Cavallino 2
Columbus 2
Des Moines 2
Dhaka 2
Esslingen am Neckar 2
Figino 2
Florence 2
Florianópolis 2
Gatchina 2
Grimsby 2
Guarulhos 2
Jiaxing 2
Johannesburg 2
Lahore 2
Madrid 2
Manchester 2
Marcianise 2
Medellín 2
Totale 1.265
Salva come PNG Salva come JPEG
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 119
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 102
Prevalence of Non-Erosive Esophageal Phenotypes in children: a European multicenter study 89
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 89
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 89
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report 84
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 84
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 79
Cardiotoxicity of anti-HER2 drugs in the treatment of metastatic breast cancer: Case report 78
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 78
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 78
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 77
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 74
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 74
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 70
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 67
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 65
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 60
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 59
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program 59
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis 57
Economic Evaluation Of A New Non-Antibiotic First-line Treatment Of Recurrent Urinary Tract Infections 55
Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations 55
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 55
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) 54
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 50
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 47
Ramucirumab In Gastric Cancer Treatment: An Economic Evaluation 46
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 46
Frontline therapy CLL without 17p del/p53 aberrations: systematic review and Bayesian network meta-analysis 45
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis 38
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients. 37
Why Do You Treat pCR Patient With Pertuzumab and Trastuzumab? 33
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 33
Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper 31
Totale 2.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 1 17 0 2 0 9 4 8 2 2
2022/2023176 24 9 5 8 14 15 4 7 26 28 31 5
2023/2024139 44 10 12 6 7 26 1 1 0 7 13 12
2024/2025495 32 13 11 8 20 78 15 20 42 8 104 144
2025/20261.277 74 114 153 188 123 60 130 93 121 91 91 39
2026/202788 20 68 0 0 0 0 0 0 0 0 0 0
Totale 2.256